ARRY: Summary for Array BioPharma Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 12:04am EST - Canadian Markets open in 9 hours and 26 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Array BioPharma, Inc. (ARRY)

On Feb 9: 2.40 USD

0.01 (0.41%)

MORE ON ARRY

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Array BioPharma Inc. (NGM:ARRY) Delayed quote data

After Hours: 2.40 0.00 (0.00%) as of 4:34pm EST on 02/09/10

Last Trade:	2.40 USD
Trade Time:	Feb 9
Change:	0.01 (0.41%)
Prev Close:	2.41
Open:	2.43
Bid:	1.50 x 100
Ask:	3.33 x 100
1y Target Est:	5.66

Day's Range:	2.35 - 2.44
52wk Range:	1.68 - 4.65
Volume:	250,779
Avg Vol (3m):	635,533
Market Cap:	118.34M
P/E (ttm):	N/A
EPS (ttm):	-2.13
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add ARRY to Portfolio

Download Data

HEADLINES

•	ARRAY BIOPHARMA INC Financials
	EDGAR Online Financials (Fri, Feb 5)

•	Dow down 26; Array BioPharma up 7%
	at bizjournals.com (Wed, Feb 3)

•	Lower Q2 Loss for Array Bio
	Zacks.com (Tue, Feb 2)

•	Array BioPharma Inc. F2Q10 (Qtr End 12/31/09) Earnings Call Transcript
	at Seeking Alpha (Tue, Feb 2)

•	Array BioPharma, Sterling Financial: Early Volume Plays
	at TheStreet.com (Tue, Feb 2)

•	New Star Analyst Rankings for Array BioPharma Inc.
	StarMine (Tue, Feb 2)

•	ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Tue, Feb 2)

•	UPDATE - Array BioPharma posts smaller-than-expected Q2 loss
	at Reuters (Mon, Feb 1)

•	ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
	EDGAR Online (Mon, Feb 1)

•	Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2010
	Business Wire (Mon, Feb 1)

•	Array BioPharma to Present at the 12th Annual BIO CEO & Investor Conference
	Business Wire (Mon, Feb 1)

More Headlines for ARRY...

ANALYST

EPS Est (next year) (Jun-10) :	-1.66
EPS Est (in 2 years) (Jun-11) :	-1.53
Avg Rec (current)*:	2.0
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer, inflammatory, and metabolic diseases in North America, Europe, and Asia Pacific.

Full Company Profile

Add to Portfolio

Email to a Friend

•